Ondine Biomedical Inc. is a Canadian life sciences company that has emerged as a global leader in photodisinfection-based therapies for preventing and treating a wide range of infections, including those caused by drug-resistant pathogens. Their patented platform technology offers solutions for infections in healthcare and industrial settings, with recent studies demonstrating up to an 84% reduction in postoperative infection rates in major Canadian hospitals.
Their flagship product, Steriwave, is a rapid nasal decolonization therapy that effectively eradicates a broad spectrum of pathogens in just minutes, significantly reducing the risk of healthcare-associated infections. Ondine Biomedical is dedicated to developing innovative products to combat antimicrobial resistance and improve patient outcomes, with a focus on safe, fast, and cost-effective solutions for complex infections.
Generated from the website